P-CD19CD20-ALLO1 Allogeneic CAR-T Cells

· Poseida Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P-CD19CD20-ALLO1 Allogeneic CAR-T Cells, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies [Phase 1]